These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 18300623)

  • 1. [Mental disorders--malingering].
    Bonshtein U
    Harefuah; 2008 Jan; 147(1):43-8, 94. PubMed ID: 18300623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of the MMPI-2-RF (Restructured Form) validity scales in detecting malingering in a criminal forensic setting: a known-groups design.
    Sellbom M; Toomey JA; Wygant DB; Kucharski LT; Duncan S
    Psychol Assess; 2010 Mar; 22(1):22-31. PubMed ID: 20230148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between Symptom Validity Test failure and scores on the MMPI-2-RF validity and substantive scales.
    Gervais RO; Wygant DB; Sellbom M; Ben-Porath YS
    J Pers Assess; 2011; 93(5):508-17. PubMed ID: 21859291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between malingerers' intelligence and MMPI-2 knowledge and their ability to avoid detection.
    Pelfrey WV
    Int J Offender Ther Comp Criminol; 2004 Dec; 48(6):649-63. PubMed ID: 15538024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of the MMPI-2 malingering discriminant function index in the detection of malingering: a study of criminal defendants.
    Toomey JA; Kucharski LT; Duncan S
    Assessment; 2009 Mar; 16(1):115-21. PubMed ID: 18607009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative analysis of MMPI-2 malingering detection models among inmates.
    Steffan JS; Morgan RD; Lee J; Sellbom M
    Assessment; 2010 Jun; 17(2):185-96. PubMed ID: 20124427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification accuracy of MMPI-2 validity scales in the detection of pain-related malingering: a known-groups study.
    Bianchini KJ; Etherton JL; Greve KW; Heinly MT; Meyers JE
    Assessment; 2008 Dec; 15(4):435-49. PubMed ID: 18539782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malingering of PTSD: forensic and diagnostic considerations, characteristics of malingerers and clinical presentations.
    Hall RC; Hall RC
    Gen Hosp Psychiatry; 2006; 28(6):525-35. PubMed ID: 17088169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of the MMPI-2-RF in detecting non-credible somatic complaints.
    Sellbom M; Wygant D; Bagby M
    Psychiatry Res; 2012 May; 197(3):295-301. PubMed ID: 22405634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malingering as a categorical or dimensional construct: the latent structure of feigned psychopathology as measured by the SIRS and MMPI-2.
    Walters GD; Rogers R; Berry DT; Miller HA; Duncan SA; McCusker PJ; Payne JW; Granacher RP
    Psychol Assess; 2008 Sep; 20(3):238-47. PubMed ID: 18778160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the Minnesota multiphasic personality inventory (MMPI) to identify malingering mental retardation.
    Keyes DW
    Ment Retard; 2004 Apr; 42(2):151-3. PubMed ID: 15008639
    [No Abstract]   [Full Text] [Related]  

  • 12. Psychometric perspectives on detection of malingering of pain: use of the Minnesota Multiphasic Personality Inventory-2.
    Arbisi PA; Butcher JN
    Clin J Pain; 2004; 20(6):383-91. PubMed ID: 15502681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critiquing symptom validity tests for posttraumatic stress disorder: a modification of Hartman's criteria.
    Morel KR; Marshman KC
    J Anxiety Disord; 2008 Dec; 22(8):1542-50. PubMed ID: 18423958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a new classificatory model of malingering.
    Rogers R
    Bull Am Acad Psychiatry Law; 1990; 18(3):323-33. PubMed ID: 2245247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maximizing internal and external validity in MMPI malingering research: a study of a military population.
    Viglione DJ; Fals-Stewart W; Moxham E
    J Pers Assess; 1995 Dec; 65(3):502-13. PubMed ID: 16367712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scores on the MMPI-2-RF scales as a function of increasing levels of failure on cognitive symptom validity tests in a military sample.
    Jones A; Ingram MV; Ben-Porath YS
    Clin Neuropsychol; 2012; 26(5):790-815. PubMed ID: 22709365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feigning schizophrenic disorders on the MMPI-2: detection of coached simulators.
    Rogers R; Bagby RM; Chakraborty D
    J Pers Assess; 1993 Apr; 60(2):215-26. PubMed ID: 8473961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of feigned mental disorders: a meta-analysis of the MMPI-2 and malingering.
    Rogers R; Sewell KW; Martin MA; Vitacco MJ
    Assessment; 2003 Jun; 10(2):160-77. PubMed ID: 12801188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of somatoform symptomatology on credibility of cognitive performance.
    Boone KB; Lu PH
    Clin Neuropsychol; 1999 Nov; 13(4):414-9. PubMed ID: 10806453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detecting malingering in traumatic brain injury and chronic pain with an abbreviated version of the Meyers Index for the MMPI-2.
    Aguerrevere LE; Greve KW; Bianchini KJ; Meyers JE
    Arch Clin Neuropsychol; 2008; 23(7-8):831-8. PubMed ID: 18715751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.